Albireo Pharma, Inc.

CIK 1322505 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Albireo Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2024SC 13G/A0001172661-24-000906
Apr 10, 2023SC 13G/A0001623632-23-000464
Mar 14, 202315-12G0001193125-23-070083
Mar 8, 2023EFFECT9999999995-23-000542
Mar 8, 2023EFFECT9999999995-23-000539
Mar 8, 2023SC 13G/A0001306550-23-008757
Mar 8, 2023EFFECT9999999995-23-000537
Mar 8, 2023EFFECT9999999995-23-000538
Mar 8, 2023EFFECT9999999995-23-000540
Mar 3, 202340001209191-23-015092
Mar 2, 2023POS AM0001193125-23-058268
Mar 2, 2023SC 14D9/A0001104659-23-027755
Mar 2, 2023S-8 POS0001193125-23-058282
Mar 2, 202325-NSE0001354457-23-000140
Mar 2, 2023S-8 POS0001193125-23-058285
Mar 2, 202340001209191-23-014786
Mar 2, 2023POS AM0001193125-23-058280
Mar 2, 202340001209191-23-014778
Mar 2, 202340001209191-23-014808
Mar 2, 2023POS AM0001193125-23-058265
Mar 2, 202340001209191-23-014736
Mar 2, 202340001209191-23-014763
Mar 2, 2023S-8 POS0001193125-23-058276
Mar 2, 2023S-8 POS0001193125-23-058287
Mar 2, 2023S-8 POS0001193125-23-058279